MILAN

米兰

,

，

April 30, 2026

2026年4月30日

/PRNewswire/ -- Demetra, an innovative and independent international medical company leader providing bone cements, spacers and biomaterials for orthopedic, spine and neuro applications and orthopedic infection control, announces the successful completion of the acquisition of

/PRNewswire/ -- 德米特拉（Demetra），一家为骨科、脊柱和神经应用以及骨科感染控制提供骨水泥、间隔物和生物材料的创新型独立国际医疗公司领导者，宣布成功完成收购。

Maxxspine Innovative GmbH

马克斯斯派恩创新有限公司

, a German-based company specialized in advanced spinal surgery solutions. The transaction further strengthens Demetra's position as a benchmark international group in spine surgery.

，一家总部位于德国的公司，专注于先进的脊柱手术解决方案。此次交易进一步巩固了Demetra作为脊柱手术领域的国际标杆集团的地位。

The acquisition has been completed by

收购已经完成

Osartis GmbH

奥萨蒂斯有限公司

, a Demetra Group company, which has acquired

，一家德墨忒尔集团的公司，已经收购了

100% ownership and full control of Maxxspine Innovative GmbH

完全拥有并全面控制Maxxspine Innovative GmbH

, effective as of today.

，自今日起生效。

Founded in Germany and established in 2010, Maxxspine is recognized for the development and distribution of cutting–edge medical devices for spinal surgery, with a strong presence in the German market and growing international footprint. Through this acquisition, Demetra significantly expands its spine portfolio and reinforces its proximity to surgeons and healthcare professionals in key European markets and beyond..

总部位于德国并于2010年成立，Maxxspine因其开发和分销用于脊柱手术的尖端医疗设备而受到认可，在德国市场占有重要地位，并且国际影响力不断扩大。通过此次收购，Demetra大幅扩展了其脊柱产品组合，并加强了与欧洲主要市场及其他地区外科医生和医疗专业人士的紧密联系。

For over 40 years, Demetra has been a trusted partner to healthcare professionals worldwide, improving the lives of more than three million patients through advanced solutions in infection control, prosthesis fixation, orthobiologics and minimally invasive surgery. Operating through successfully established companies such as Tecres, Osartis and OsteoRemedies, Demetra continues to invest in innovation, people and long–term sustainable growth..

四十多年来，Demetra 一直是全球医疗专业人士值得信赖的合作伙伴，通过在感染控制、假体固定、骨生物学和微创手术方面的先进解决方案，改善了超过三百万患者的生活。依托 Tecres、Osartis 和 OsteoRemedies 等成功建立的公司，Demetra 持续在创新、人才以及长期可持续增长方面进行投资。

Following the completion of the transaction, Osartis will take global responsibility for Maxxspine's activities and will work closely with the existing management and teams over the coming months to ensure a smooth integration and continuity for customers and partners.

交易完成后，Osartis 将承担 Maxxspine 活动的全球责任，并在未来几个月与现有管理层和团队密切合作，确保客户和合作伙伴的平稳整合与持续性。

Volker Ludwig, CEO of Maxxspine Innovation

沃尔克·路德维希，Maxxspine创新公司的首席执行官

, stated:

，表示：

'Becoming part of a strong and ambitious international group like Demetra provides the ideal platform to further develop what I have built over the years. This step makes me proud of our journey so far and confident in the results we can achieve together, with Maxxspine's values of trust and professionalism fully respected and carried forward'..

“成为像Demetra这样强大且雄心勃勃的国际集团的一员，为我提供了进一步发展多年来所建立事业的理想平台。这一步让我为我们迄今为止的旅程感到自豪，并对我们可以共同取得的成果充满信心，同时Maxxspine的信任和专业价值观也得到了充分尊重和延续。”

After more than 20 years of delivering innovative, user-specific solutions in the spine business, we are now taking the next strategic step.

在脊柱业务领域提供了20多年的创新性、针对用户的解决方案之后，我们现在正迈出下一个战略步骤。

Through our integration into the Demetra Group, we significantly expand our capabilities, reach, and overall strength. This positions us to be recognized by both customers and suppliers as a reliable and forward-looking partner for the future. With Demetra at our side, we are unlocking new opportunities—particularly in the field of kyphoplasty.

通过我们融入Demetra集团，我们大幅扩展了我们的能力、覆盖范围和整体实力。这使我们能够被客户和供应商视为未来可靠且前瞻性的合作伙伴。在Demetra的支持下，我们正在开启新的机遇，特别是在椎体后凸成形术领域。

Together, we are well equipped to keep pace with global leaders and to further strengthen our position in this dynamic market..

我们共同携手，完全有能力跟上全球领导者的步伐，并进一步巩固我们在这个动态市场中的地位。

Positioning for growth in the EU and beyond

在欧盟及更远地区实现增长的定位

'

'

The acquisition of

收购

Maxxspine is fully aligned with Demetra's strategy to strengthen its presence in the key European spine surgery markets. By integrating highly specialised companies like Maxxspine, we further enhance our ability to stay close to surgeons and patients, delivering innovative solutions and reinforcing our role as a trusted international partner in spine care.

Maxxspine 完全符合 Demetra 加强其在欧洲主要脊柱手术市场地位的战略。通过整合像 Maxxspine 这样高度专业化的公司，我们进一步提升了贴近外科医生和患者的能力，提供创新的解决方案，并巩固我们作为脊柱护理领域值得信赖的国际合作伙伴的角色。

' commented

' 已注释

Michele Perrino, CEO of Demetra

米凯莱·佩里诺，德墨忒尔公司首席执行官

.

。

About Demetra.

关于得墨忒耳。

Demetra is an independent global healthcare group specialized in the development of PJI treatment solutions and minimally invasive surgical solutions. With a presence in over 100 countries and a growing portfolio of patented technologies, Demetra is committed to advancing patient care by investing in people, research, and sustainable innovation..

德米特拉是一家独立的全球医疗保健集团，专注于开发PJI治疗解决方案和微创手术解决方案。业务遍及100多个国家，并拥有不断增长的专利技术组合。德米特拉通过投资于人才、研究和可持续创新，致力于提升患者护理水平。

Logo -

标志 -

https://mma.prnewswire.com/media/2742564/5943698/Demetra_Logo.jpg

https://mma.prnewswire.com/media/2742564/5943698/Demetra_Logo.jpg

21

21

%

%

more press release views with

更多新闻发布观点与

Request a Demo

请求演示